Heart-Type Fatty Acid Binding Protein and Ischemia-Modified Albumin for Detection of Myocardial Infarction After Coronary Artery Bypass Graft Surgery

Annals of Thoracic Surgery

Volumn 104, Issue 1, 2017, Pages 130-137

  Thielmann, Matthias ^a   Pasa, Susanne ^a   Holst, Torulv ^a   Wendt, Daniel ^a   Dohle, Daniel Sebastian ^a   Demircioglu, Ender ^a   Sharma, Vikram ^b,c   Jakob, Heinz ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Hatter Cardiovascular Institute   (United Kingdom)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; ISCHEMIA MODIFIEDI ALBUMIN; TROPONIN I; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HUMAN SERUM ALBUMIN; ISCHEMIA-MODIFIED ALBUMIN; SERUM ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAPHY; HEART INFARCTION; HUMAN; IMMUNOASSAY ANALYZER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; FEMALE; FOLLOW UP; MALE; PROCEDURES; PROSPECTIVE STUDY;

AGED; BIOMARKERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SERUM ALBUMIN; SERUM ALBUMIN, HUMAN;

EID: 85012877674     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2016.10.051     Document Type: Article

References (26)

1. Croal, B.L., Hillis, G.S., Gibson, P.H., et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114 (2006), 1468–1475.
2. Fellahi, J.L., Gue, X., Richomme, X., Monier, E., Guillou, L., Riou, B., Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 99 (2003), 270–274.
3. Force, T., Hibberd, P., Weeks, G., et al. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. Circulation 82 (1990), 903–912.
4. Lehrke, S., Steen, H., Sievers, H.H., et al. Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem 50 (2004), 1560–1567.
5. Thielmann, M., Massoudy, P., Schmermund, A., et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 26 (2005), 2440–2447.
6. Thielmann, M., Massoudy, P., Jaeger, B.R., et al. Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery. Eur J Cardiothorac Surg 30 (2006), 117–125.
7. Thielmann, M., Massoudy, P., Marggraf, G., et al. Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. Eur J Cardiothorac Surg 26 (2004), 102–109.
8. Fransen, E.J., Maessen, J.G., Hermens, W.T., Glatz, J.F., Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients. Ann Thorac Surg 65 (1998), 48–53.
9. Petzold, T., Feindt, P., Sunderdiek, U., Boeken, U., Fischer, Y., Gams, E., Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 19 (2001), 859–864.
10. Suzuki, K., Sawa, Y., Kadoba, K., et al. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations. Ann Thorac Surg 65 (1998), 54–58.
11. Van Nieuwenhoven, F.A., Kleine, A.H., Wodzig, W.H., et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92 (1995), 2848–2854.
12. Bar-Or, D., Winkler, J.V., Vanbenthuysen, K., Harris, L., Lau, E., Hetzel, F.W., Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001), 985–991.
13. Liebetrau, C., Nef, H.M., Dorr, O., et al. Release kinetics of early ischaemic biomarkers in a clinical model of acute myocardial infarction. Heart 100 (2014), 652–657.
14. Sbarouni, E., Georgiadou, P., Voudris, V., Ischemia modified albumin changes—review and clinical implications. Clin Chem Lab Med 49 (2011), 177–184.
15. Sinha, M.K., Gaze, D.C., Tippins, J.R., Collinson, P.O., Kaski, J.C., Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 107 (2003), 2403–2405.
16. Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Eur Heart J 33 (2012), 2551–2567.
17. Thygesen, K., Alpert, J.S., White, H.D., et al., and the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 116 (2007), 2634–2653.
18. Moussa, I.D., Klein, L.W., Shah, B., et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization. An expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol 62 (2013), 1563–1570.
19. Panteghini, M., Pagani, F., Yeo, K.T., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 50 (2004), 327–332.
20. Kleine, A.H., Glatz, J.F., Van Nieuwenhoven, F.A., Van der Vusse, G.J., Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116 (1992), 155–162.
21. Rader, F., Pujara, A.C., Pattakos, G., et al. Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery. Heart Rhythm 10 (2013), 153–157.
22. Viswanathan, K., Kilcullen, N., Morrell, C., et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 55 (2010), 2590–2598.
23. Chek, J., Dusek, J., Stasek, J., et al. Role of ischemia-modified albumin in estimating the extent and scope of cardiac ischemia in patients with ST elevation myocardial infarction. Heart Vessels 26 (2011), 622–627.
24. Dong, S.Y., Wang, X.J., Xiao, F., Wang, J., Li, Y.F., Li, Y., Detection of perioperative myocardial infarction with ischemia-modified albumin. Asian Cardiovasc Thorac Ann 20 (2012), 252–256.
25. Kanko, M., Yavuz, S., Duman, C., Hosten, T., Oner, E., Berki, T., Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery. J Cardiothorac Surg, 7, 2012, 3.
26. Sbarouni, E., Georgiadou, P., Panagiotakos, D., Alivizatos, P.A., Voudris, V., Increased ischaemia modified albumin following coronary artery bypass grafting. Biomarkers 14 (2009), 38–42.